These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18243699)

  • 1. Inhaled adenosine A(2A) receptor agonists for the treatment of chronic obstructive pulmonary disease.
    Mantell SJ; Stephenson PT; Monaghan SM; Maw GN; Trevethick MA; Yeadon M; Keir RF; Walker DK; Jones RM; Selby MD; Batchelor DV; Rozze S; Chavaroche H; Hobson TJ; Dodd PG; Lemaitre A; Wright KN; Stuart EF
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1284-7. PubMed ID: 18243699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SAR of a series of inhaled A(2A) agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data.
    Mantell SJ; Stephenson PT; Monaghan SM; Maw GN; Trevethick MA; Yeadon M; Walker DK; Selby MD; Batchelor DV; Rozze S; Chavaroche H; Lemaitre A; Wright KN; Whitlock L; Stuart EF; Wright PA; Macintyre F
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4471-5. PubMed ID: 19501510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of the cardiovascular response of posterior hypothalamic adenosine A(2A) receptor stimulation by adenylate cyclase and KATP channel blockade in anesthetized rats.
    Lee CB; Koh HC
    Auton Neurosci; 2009 Mar; 146(1-2):70-5. PubMed ID: 19138885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highlights on the development of A(2A) adenosine receptor agonists and antagonists.
    Cristalli G; Cacciari B; Dal Ben D; Lambertucci C; Moro S; Spalluto G; Volpini R
    ChemMedChem; 2007 Mar; 2(3):260-81. PubMed ID: 17177231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and optimization of potent and selective functional antagonists of the human adenosine A2B receptor.
    Bedford ST; Benwell KR; Brooks T; Chen I; Comer M; Dugdale S; Haymes T; Jordan AM; Kennett GA; Knight AR; Klenke B; LeStrat L; Merrett A; Misra A; Lightowler S; Padfield A; Poullennec K; Reece M; Simmonite H; Wong M; Yule IA
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5945-9. PubMed ID: 19733067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine receptor modelling. A1/A2a selectivity.
    Tuccinardi T; Ortore G; Manera C; Saccomanni G; Martinelli A
    Eur J Med Chem; 2006 Mar; 41(3):321-9. PubMed ID: 16427161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system.
    Chiang MC; Chen HM; Lai HL; Chen HW; Chou SY; Chen CM; Tsai FJ; Chern Y
    Hum Mol Genet; 2009 Aug; 18(16):2929-42. PubMed ID: 19443488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of adenosine A2A agonist during hemorrhagic shock: a simple intervention may result in a complex response.
    Ramakers BP; Riksen NP; van der Hoeven JG; Smits P; Pickkers P
    Crit Care Med; 2006 Dec; 34(12):3059; author reply 3059-60. PubMed ID: 17130711
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of adenosine A 2A receptors in the rat lumbar spinal cord and implications in the modulation of N-methyl-d-aspartate receptor currents.
    Guntz E; Dumont H; Pastijn E; d'Exaerde Ade K; Azdad K; Sosnowski M; Schiffmann SN; Gall D
    Anesth Analg; 2008 Jun; 106(6):1882-9. PubMed ID: 18499627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine receptor agonists attenuate the development of diazepam withdrawal-induced sensitization in mice.
    Listos J; Talarek S; Fidecka S
    Eur J Pharmacol; 2008 Jun; 588(1):72-7. PubMed ID: 18466897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalation by design: dual pharmacology β-2 agonists/M3 antagonists for the treatment of COPD.
    Jones LH; Baldock H; Bunnage ME; Burrows J; Clarke N; Coghlan M; Entwistle D; Fairman D; Feeder N; Fulton C; Hilton L; James K; Jones RM; Kenyon AS; Marshall S; Newman SD; Osborne R; Patel S; Selby MD; Stuart EF; Trevethick MA; Wright KN; Price DA
    Bioorg Med Chem Lett; 2011 May; 21(9):2759-63. PubMed ID: 21075627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in adenosine A2A receptor ligands.
    Cristalli G; Müller CE; Volpini R
    Handb Exp Pharmacol; 2009; (193):59-98. PubMed ID: 19639279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GETAWAY descriptors to predicting A(2A) adenosine receptors agonists.
    González MP; Terán C; Teijeira M; González-Moa MJ
    Eur J Med Chem; 2005 Nov; 40(11):1080-6. PubMed ID: 16006015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatments for chronic obstructive pulmonary disease and viable formulation/device options for inhalation therapy.
    Onoue S; Misaka S; Kawabata Y; Yamada S
    Expert Opin Drug Deliv; 2009 Aug; 6(8):793-811. PubMed ID: 19558334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treating lung inflammation with agonists of the adenosine A2A receptor: promises, problems and potential solutions.
    Trevethick MA; Mantell SJ; Stuart EF; Barnard A; Wright KN; Yeadon M
    Br J Pharmacol; 2008 Oct; 155(4):463-74. PubMed ID: 18846036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!].
    Rochat T
    Rev Med Suisse; 2008 Jan; 4(140):155-7. PubMed ID: 18309880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease.
    D'Alimonte I; D'Auro M; Citraro R; Biagioni F; Jiang S; Nargi E; Buccella S; Di Iorio P; Giuliani P; Ballerini P; Caciagli F; Russo E; De Sarro G; Ciccarelli R
    Eur J Neurosci; 2009 Sep; 30(6):1023-35. PubMed ID: 19723291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and application of locally delivered agonists of the adenosine A(2A) receptor.
    Mantell S; Jones R; Trevethick M
    Expert Rev Clin Pharmacol; 2010 Jan; 3(1):55-72. PubMed ID: 22111533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.